公开(公告)号：EP3327010B1

公开(公告)日：2019-12-25

申请号：EP16817233.6

申请日：2016-06-28

申请人： Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China

发明人： LI, Song ,  XIAO, Junhai ,  LYU, Boqun ,  WANG, Hongqiang ,  ZHONG, Wu ,  WANG, Lili ,  ZHENG, Zhibing ,  XIE, Yunde ,  ZHOU, Xinbo ,  LI, Xingzhou ,  WANG, Xiaokui

IPC分类号： C07D279/12 ,  A61K31/54 ,  A61P25/00 ,  A61P25/28 ,  A61P25/16 ,  A61P21/00

公开(公告)号：EP3327010A1

公开(公告)日：2018-05-30

申请号：EP16817233.6

申请日：2016-06-28

申请人： Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China

发明人： LI, Song ,  XIAO, Junhai ,  LYU, Boqun ,  WANG, Hongqiang ,  ZHONG, Wu ,  WANG, Lili ,  ZHENG, Zhibing ,  XIE, Yunde ,  ZHOU, Xinbo ,  LI, Xingzhou ,  WANG, Xiaokui

IPC分类号： C07D279/12 ,  A61K31/54 ,  A61P25/00 ,  A61P25/28 ,  A61P25/16 ,  A61P21/00

摘要： The invention belongs to the technical field of medicines. In particular, the invention relates to a thiazideamide derivative compound or a pharmaceutically acceptable salt or solvate thereof, a pharmaceutical composition comprising the compound or a pharmaceutically acceptable salt or solvate thereof, a method for preparing the compound or a pharmaceutically acceptable salt or solvate thereof, and a use of the compound or a pharmaceutically acceptable salt or solvate thereof. For example, the compound or a pharmaceutically acceptable salt or solvate thereof according to the invention can be used to prevent and/or treat a neurodegenerative disease or a neuropathic disease caused by a physical trauma or a related disease.